Last Updated: 31-07-2025 | Format: PDF | Report ID:20257 | Author: Sophia
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $4,320 Million |
| What is the projected market size by 2035? | $11,300 Million |
| What is the market CAGR from 2025 to 2035? | 10.1% |
| Which region dominates the market? | United States (78%) |
| Which product/service type dominates the market? | Reagents (40%) |
| Which application leads the market? | PCR (35%) |
| Who are the major buyers? | Research Institutions (44%), Biotech/Pharma (32%) |
| What are the key market growth drivers? | Strong investments in genomics research; The surge in infectious disease diagnostics post-pandemic has significantly raised the use of PCR and sequencing kits |
| What are the major market challenges? | Supply chain complexities and dependency on global raw material sourcing have led to periodic shortages and delays; Stringent regulatory frameworks and product approval timelines continue to challenge new entrants and slow down market access |
| What is the forecast period? | 2026–2035 |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| Who are the key market players? | Thermo Fisher Scientific, Merck KGaA, New England Biolabs, Agilent Technologies, Bio-Rad Laboratories, Qiagen N.V., Takara Bio, Promega Corporation, Illumina, F. Hoffmann-La Roche, Enzymatics, Lucigen Corporation, Jena Bioscience, Bioline, GenScript |
North America Protein Crystallization & Crystallography Market: by Type (Reagents, Instruments, Automation & Robotics, Software & Services), Application (Drug Discovery, Structural Biology, Disease Diagnostics, Industrial Applications), Distribution Channels (Online, Offline), Technology (X-ray Crystallography, NMR Spectroscopy, Cryo-Electron Microscopy, Microfluidics), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Expression Vectors Market: by Type (Plasmid Vectors, Viral Vectors, Bacterial Artificial Chromosomes (BAC), Yeast Artificial Chromosomes (YAC), Cosmids, Others), Application (Therapeutic, Research, Industrial, Diagnostic, Vaccine Development, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Specialty Stores, Retail Pharmacies, Others), Technology (Molecular Cloning, Recombinant DNA Technology, Synthetic Biology, Gene Editing, Cell-free Expression Systems, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
US Early Stage Cancer Market Market: by Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Other Cancers), Application (Diagnosis, Screening, Monitoring, Prognosis, Treatment Planning, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Research Institutes, Retail Pharmacies, Online Providers, Others), Technology (Imaging, Molecular Diagnostics, Genomics, Biomarker Testing, Others), Organization Size (Small, Medium, Large) and By US Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Europe Early Stage Cancer Market: by Type (Biomarker-based Screening, Imaging-based Screening, Liquid Biopsy, Molecular Diagnostics, Immunoassay, Others), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Others), Distribution Channels (Hospitals, Diagnostic Centers, Cancer Research Institutes, Specialty Clinics, Ambulatory Surgical Centers, Others), Technology (PCR, Next-Generation Sequencing, Immunohistochemistry, In Situ Hybridization, Flow Cytometry, Others), Organization Size (Small, Medium, Large) and By Europe Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Newborn Screening Market: by Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types), Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels), Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025